|
TBCC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.43910455669061E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68060000360626E-08 |
| Normal-vs-Stage2 |
3.94409999999734E-05 |
| Normal-vs-Stage3 |
3.63270524772474E-11 |
| Normal-vs-Stage4 |
1.21190000257343E-08 |
| Stage1-vs-Stage2 |
8.879400E-01 |
| Stage1-vs-Stage3 |
2.916200E-02 |
| Stage1-vs-Stage4 |
5.100000E-02 |
| Stage2-vs-Stage3 |
2.157400E-01 |
| Stage2-vs-Stage4 |
2.033200E-01 |
| Stage3-vs-Stage4 |
8.180200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.70840058450517E-11 |
| Normal-vs-AfricanAmerican |
2.07340000002443E-06 |
| Normal-vs-Asian |
2.118800E-03 |
| Caucasian-vs-AfricanAmerican |
4.099400E-01 |
| Caucasian-vs-Asian |
2.735600E-02 |
| AfricanAmerican-vs-Asian |
2.855600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29560000009066E-07 |
| Normal-vs-Female |
9.35107546951031E-12 |
| Male-vs-Female |
8.349700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.07940000271256E-08 |
| Normal-vs-Age(41-60Yrs) |
3.14349990482299E-10 |
| Normal-vs-Age(61-80Yrs) |
9.85180048651557E-10 |
| Normal-vs-Age(81-100Yrs) |
3.795400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.443400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.791200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.105600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.962800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.558600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.653800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.488200E-02 |
| Classical-VS-Follicular |
1.347020E-01 |
| Classical-VS-Other |
4.030000E-01 |
| Classical-VS-Normal |
3.79340000522532E-08 |
| Tall-VS-Follicular |
2.436600E-01 |
| Tall-VS-Other |
1.064970E-01 |
| Tall-VS-Normal |
1.36829999553001E-08 |
| Follicular-VS-Other |
2.104400E-01 |
| Follicular-VS-Normal |
5.74559999577673E-09 |
| Other-VS-Normal |
3.849200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03120000316537E-08 |
| Normal-vs-N1 |
4.67729999176214E-09 |
| N0-vs-N1 |
8.592300E-02 |
|
|
